Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Bradshaw

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Sexually Transmitted Infections|September 25, 2012
Otosyphilis: missed opportunities for early treatment?Daniel Bradshaw, Sanjeeva Pallawela, Mark Nelson, et al.
Patient Education and Counseling|May 14, 2013
Acceptability of video recordings of consultations in HIV and genitourinary medicine (GUM)Daniel Bradshaw, Charlotte E Cohen, Sara Day, et al.
The Journal of Infectious Diseases|July 30, 2008
Direct ex vivo evaluation of long-lived protective antiviral memory B cell responses against hepatitis B virusScott M Ward, Prabhjeet Phalora, Daniel Bradshaw, et al.
BMJ Open|July 9, 2020
Protocol for a phase IV, open-label feasibility study investigating non-invasive markers of hepatic fibrosis in people living with HIV-1 and non-alcoholic fatty liver disease randomised to receiving optimised background therapy (OBT) plus maraviroc or OBT aloneDaniel Bradshaw, Yvonne Gilleece, Sumita Verma, et al.
AIDS (London, England)|July 29, 2016
A case of hereditary coproporphyria precipitated by efavirenzRosanna Grimes, Yvonne Gilleece, Timothy Appleby, et al.
Lancet (London, England)|May 25, 2024
Why not eliminate HTLV-1 while eliminating HIV-1?Goedele N Maertens, Damian F J Purcell, Carolina Rosadas, et al.
The Journal of Infection|March 7, 2025
Direct-acting antiviral treatment outcomes in people infected with endemic compared to epidemic hepatitis C virus subtypes in EnglandLaura T Phillips, Daniel Bradshaw, Simon Packer, et al.
The Journal of Infectious Diseases|October 9, 2014
A comparison of seminal hepatitis C virus (HCV) RNA levels during recent and chronic HCV infection in HIV-infected and HIV-uninfected individualsDaniel Bradshaw, Francois Lamoury, Beth Catlett, et al.
The Journal of Infection|June 14, 2025
Infants of hepatitis B surface antigen positive women of Black ethnicity in the UK may be at risk of acquiring human T-cell lymphotropic virus type 1Daniel Bradshaw, Panida Silalang, Nick Andrews, et al.
The Journal of Infectious Diseases|September 26, 2025
Real-world prevalence of non-integrase INSTI resistance-associated mutations and virological outcomes in people who have recently acquired HIV-1 in the UKChristine Kelly, James S Lester, Daniel Bradshaw, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Sexually Transmitted Infections|September 25, 2012
Otosyphilis: missed opportunities for early treatment?Daniel Bradshaw, Sanjeeva Pallawela, Mark Nelson, et al.
Patient Education and Counseling|May 14, 2013
Acceptability of video recordings of consultations in HIV and genitourinary medicine (GUM)Daniel Bradshaw, Charlotte E Cohen, Sara Day, et al.
The Journal of Infectious Diseases|July 30, 2008
Direct ex vivo evaluation of long-lived protective antiviral memory B cell responses against hepatitis B virusScott M Ward, Prabhjeet Phalora, Daniel Bradshaw, et al.
BMJ Open|July 9, 2020
Protocol for a phase IV, open-label feasibility study investigating non-invasive markers of hepatic fibrosis in people living with HIV-1 and non-alcoholic fatty liver disease randomised to receiving optimised background therapy (OBT) plus maraviroc or OBT aloneDaniel Bradshaw, Yvonne Gilleece, Sumita Verma, et al.
AIDS (London, England)|July 29, 2016
A case of hereditary coproporphyria precipitated by efavirenzRosanna Grimes, Yvonne Gilleece, Timothy Appleby, et al.
Lancet (London, England)|May 25, 2024
Why not eliminate HTLV-1 while eliminating HIV-1?Goedele N Maertens, Damian F J Purcell, Carolina Rosadas, et al.
The Journal of Infection|March 7, 2025
Direct-acting antiviral treatment outcomes in people infected with endemic compared to epidemic hepatitis C virus subtypes in EnglandLaura T Phillips, Daniel Bradshaw, Simon Packer, et al.
The Journal of Infectious Diseases|October 9, 2014
A comparison of seminal hepatitis C virus (HCV) RNA levels during recent and chronic HCV infection in HIV-infected and HIV-uninfected individualsDaniel Bradshaw, Francois Lamoury, Beth Catlett, et al.
The Journal of Infection|June 14, 2025
Infants of hepatitis B surface antigen positive women of Black ethnicity in the UK may be at risk of acquiring human T-cell lymphotropic virus type 1Daniel Bradshaw, Panida Silalang, Nick Andrews, et al.
The Journal of Infectious Diseases|September 26, 2025
Real-world prevalence of non-integrase INSTI resistance-associated mutations and virological outcomes in people who have recently acquired HIV-1 in the UKChristine Kelly, James S Lester, Daniel Bradshaw, et al.
Pageof 5